HC Wainwright & Co. Reiterates Buy on AtaiBeckley, Maintains $25 Price Target
3/17/2026
Impact: 70
Healthcare
HC Wainwright & Co. analyst Patrick R. Trucchio has reiterated a Buy rating on AtaiBeckley (NASDAQ: ATAI) and maintained a price target of $25 for the stock. No additional financial figures or strategic changes were mentioned in the article.
AI summary, not financial advice
Share: